The pruritus receptor unit: A target for novel therapies

Gil Yosipovitch

Research output: Contribution to journal › Review article

15 Citations (Scopus)

Abstract

Although the role of prostanoids in itch was actively studied a decade ago, interest in this area has waned in recent years. Andoh et al. (2007, this issue) demonstrate that the prostanoid thromboxane A2 elicits scratching through its TP receptor. Identification of new itch mediators and their respective receptors within the skin will undoubtedly be the focus of future drug development for this distressing symptom.

Original languageEnglish (US)
Pages (from-to)1857-1859
Number of pages3
JournalJournal of Investigative Dermatology
Volume127
Issue number8
DOIs
StatePublished - Aug 1 2007
Externally publishedYes

Fingerprint

Pruritus
Prostaglandins
Thromboxane Receptors
Thromboxane A2
Skin
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

The pruritus receptor unit : A target for novel therapies. / Yosipovitch, Gil.

In: Journal of Investigative Dermatology, Vol. 127, No. 8, 01.08.2007, p. 1857-1859.

Research output: Contribution to journal › Review article

Yosipovitch, G 2007, 'The pruritus receptor unit: A target for novel therapies', Journal of Investigative Dermatology, vol. 127, no. 8, pp. 1857-1859. https://doi.org/10.1038/sj.jid.5700818
Yosipovitch G. The pruritus receptor unit: A target for novel therapies. Journal of Investigative Dermatology. 2007 Aug 1;127(8):1857-1859. https://doi.org/10.1038/sj.jid.5700818
Yosipovitch, Gil. / The pruritus receptor unit : A target for novel therapies. In: Journal of Investigative Dermatology. 2007 ; Vol. 127, No. 8. pp. 1857-1859.
@article{045b198b6f6a46609b9caa6adc532c8d,
title = "The pruritus receptor unit: A target for novel therapies",
abstract = "Although the role of prostanoids in itch was actively studied a decade ago, interest in this area has waned in recent years. Andoh et al. (2007, this issue) demonstrate that the prostanoid thromboxane A2 elicits scratching through its TP receptor. Identification of new itch mediators and their respective receptors within the skin will undoubtedly be the focus of future drug development for this distressing symptom.",
author = "Gil Yosipovitch",
year = "2007",
month = "8",
day = "1",
doi = "10.1038/sj.jid.5700818",
language = "English (US)",
volume = "127",
pages = "1857--1859",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - The pruritus receptor unit

T2 - A target for novel therapies

AU - Yosipovitch, Gil

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Although the role of prostanoids in itch was actively studied a decade ago, interest in this area has waned in recent years. Andoh et al. (2007, this issue) demonstrate that the prostanoid thromboxane A2 elicits scratching through its TP receptor. Identification of new itch mediators and their respective receptors within the skin will undoubtedly be the focus of future drug development for this distressing symptom.

AB - Although the role of prostanoids in itch was actively studied a decade ago, interest in this area has waned in recent years. Andoh et al. (2007, this issue) demonstrate that the prostanoid thromboxane A2 elicits scratching through its TP receptor. Identification of new itch mediators and their respective receptors within the skin will undoubtedly be the focus of future drug development for this distressing symptom.

UR - http://www.scopus.com/inward/record.url?scp=34447546641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447546641&partnerID=8YFLogxK

U2 - 10.1038/sj.jid.5700818

DO - 10.1038/sj.jid.5700818

M3 - Review article

C2 - 17632568

AN - SCOPUS:34447546641

VL - 127

SP - 1857

EP - 1859

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 8

ER -

Access to Document